Clinical Trial Update: Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on perioperative chemotherapy with bevacizumab for colorectal carcinomatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED